- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02583035
Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy (TelOG)
There are no recommendations and few studies on the monitoring of fragile patients in the oncological treatment, both on the organizational arrangements on its interest in the prevention of functional deterioration of the patient and adaptation of the potential cancer treatment.
The oncogériatrique evaluation being time-consuming, requiring the movement of these more or less frail elderly patients, it seems difficult to envisage repeated and systematic standardized geriatric assessments during cancer treatment. Geriatric fragility can be detected by telephone. Craven et al. has already assessed the telephone follow-up by a nurse in patients treated for cancer, but with the aim to detect toxicities of cancer treatment, patients are not very old (mean age 64.8 years).
External evaluation by the nurse coordinator of UCOG (Coordination Unit in geriatric oncology) not knowing the patients included avoids bias of subjectivity in the interrogation.
However the telephone monitoring, with the aim to evaluate the evolution of geriatric frailty, has not been specifically studied in the elderly population treated for cancer, while taking oncology load.
The investigators wish to study the feasibility and validity of telephone follow-up which could eventually be used routinely to identify patients requiring further medical consultation oncogériatrique.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bayeux, France
- Centre Hospitalier
-
Caen, France, 14033
- CHU
-
Caen, France, 14400
- Centre Francois Baclesse
-
Dieppe, France
- Centre Hospitalier
-
Le Havre, France
- Centre Hospitalier du Havre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients 70 years and older with cancer or hematologic malignancies;
- Faced benefit from cancer treatment (systemic treatment, curative radiotherapy) in one of the clinical sites;
- Addressed in onco-gériatric consultation in the usual routine care sector;
- Mastery of the French language;
- Patient affiliated to the social security system;
- Patient has given its written consent.
Exclusion Criteria:
- Life expectancy <3 months
- Inability to communicate by telephone (deafness, speech disorder, ..)
- Inability collection of written consent
- Group 4 SiO (International Society of Geriatric Oncology), Performance status (PS) 4
- initial MMSE (Mini-Mental State Examination) <18/30
- oncological treatment envisaged: analgesic radiotherapy or exclusive decompressive, brain radiation therapy in toto
- Patient under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Nurse telephone contact
3 days of consultation, telephone follow-up of the patient by the nurse coordinator of the Geriatric Oncology Unit to validate
|
Nurse will contact patient 3 days before consultation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Memory on the Mini Mental Scale
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Falls on the number of falls
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Pain on the EVS (verbal scale) scale
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Autonomy on the ADL (activities of daily living) score
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Pain on the EN (numericale scale) scale
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Autonomy on the IADL (The Lawton Instrumental Activities of Daily Living Scale ) score
Time Frame: 3 months after inclusion
|
3 months after inclusion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bérengère Beauplet, MD, University Hospital, Caen
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TelOG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Nurse telephone contact
-
Centre Hospitalier Universitaire de NīmesCompletedPreoperative AnxietyFrance
-
Norwegian University of Science and TechnologyOslo University Hospital; Haukeland University Hospital; St. Olavs HospitalRecruitingMigraine | Cluster Headache | Chronic Tension-Type Headache | Hemicrania ContinuaNorway
-
Chinese University of Hong KongHospital Authority, Hong KongTerminatedType 2 Diabetes Mellitus | Acute Coronary SyndromeHong Kong
-
University of Dublin, Trinity CollegeCompleted
-
Centre Francois BaclesseTerminatedCancer | Palliative Care | HomeFrance
-
Umeå UniversityRecruitingBreast Cancer | Colorectal Cancer | Prostate CancerSweden
-
Johns Hopkins UniversityCompleted
-
NYU Langone HealthCompletedTraumatic Brain Injury | Vascular Accident, BrainUnited States
-
University of BergenCompletedDepression | Chronic Obstructive Pulmonary Disease | AnxietyNorway